MERCURY LABORATORIES
Quarterly Results Analysis [Jun2024]
MERCURY LABORATORIES Quarterly Results
Standalone | Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹23 Cr | ₹18 Cr | ₹19 Cr | ₹16 Cr | ₹22 Cr |
Expenses | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹20 Cr | ₹17 Cr | ₹18 Cr | ₹16 Cr | ₹17 Cr |
Operating Income | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹5 Cr |
Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹4 Cr |
Profit After Tax | ₹0 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹3 Cr |
EPS | ₹2.85 | ₹15.92 | ₹10.30 | ₹12.57 | ₹8.33 | ₹3.06 | ₹5.05 | ₹26.19 |
Industry Peers & Returns | 1W | 1M | 1Y |
MERCURY LABORATORIES | 4.2% | -4.1% | 19.5% |
SUN PHARMACEUTICAL INDUSTRIES | 0.1% | -4% | 52.9% |
CIPLA | 0.5% | -1.7% | 29.4% |
DR REDDYS LABORATORIES | 1.1% | -2.6% | 19.2% |
ZYDUS LIFESCIENCES | -3.6% | -8.4% | 62.9% |
DIVIS LABORATORIES | 0.7% | -0% | 70.9% |
MANKIND PHARMA | -2.8% | -0.7% | 52% |
TORRENT PHARMACEUTICALS | -0.1% | -7.2% | 58.1% |
LUPIN | -3.9% | -2.4% | 77.5% |
MERCURY LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -3.97 % |
Y-o-Y | -8.98 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2024 | ₹17 Cr | -3.97 | |
Mar2024 | ₹17 Cr | 1.47 | |
Dec2023 | ₹17 Cr | -24.79 | |
Sep2023 | ₹23 Cr | 24.19 | |
Jun2023 | ₹18 Cr | -5.71 | |
Mar2023 | ₹19 Cr | 19.72 | |
Dec2022 | ₹16 Cr | -26.46 | |
Sep2022 | ₹22 Cr | - |
MERCURY LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -39.38 % |
Y-o-Y | -3.25 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2024 | ₹2 Cr | -39.38 | |
Mar2024 | ₹3 Cr | 18.93 | |
Dec2023 | ₹2 Cr | -10.41 | |
Sep2023 | ₹2 Cr | 49.79 | |
Jun2023 | ₹2 Cr | 59.25 | |
Mar2023 | ₹1 Cr | 80.76 | |
Dec2022 | ₹1 Cr | -87.67 | |
Sep2022 | ₹5 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -36.83 % |
Y-o-Y | 6.28 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2024 | 9.64% | -36.83 | |
Mar2024 | 15.26% | 17.20 | |
Dec2023 | 13.02% | 19.12 | |
Sep2023 | 10.93% | 20.51 | |
Jun2023 | 9.07% | 68.90 | |
Mar2023 | 5.37% | 51.27 | |
Dec2022 | 3.55% | -83.26 | |
Sep2022 | 21.21% | - |
MERCURY LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -82.09 % |
Y-o-Y | -65.80 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2024 | ₹0 Cr | -82.09 | |
Mar2024 | ₹2 Cr | 54.53 | |
Dec2023 | ₹1 Cr | -18.04 | |
Sep2023 | ₹2 Cr | 50.80 | |
Jun2023 | ₹1 Cr | 172.48 | |
Mar2023 | ₹0 Cr | -39.44 | |
Dec2022 | ₹1 Cr | -80.72 | |
Sep2022 | ₹3 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -81.36 % |
Y-o-Y | -62.45 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2024 | 2.05 % | -81.36 | |
Mar2024 | 11 % | 52.35 | |
Dec2023 | 7.22 % | 8.90 | |
Sep2023 | 6.63 % | 21.43 | |
Jun2023 | 5.46 % | 188.89 | |
Mar2023 | 1.89 % | -49.33 | |
Dec2022 | 3.73 % | -73.81 | |
Sep2022 | 14.24 % | - |
MERCURY LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -82.10 % |
Y-o-Y | -65.79 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2024 | ₹2.85 | -82.10 | |
Mar2024 | ₹15.92 | 54.56 | |
Dec2023 | ₹10.3 | -18.06 | |
Sep2023 | ₹12.57 | 50.90 | |
Jun2023 | ₹8.33 | 172.22 | |
Mar2023 | ₹3.06 | -39.41 | |
Dec2022 | ₹5.05 | -80.72 | |
Sep2022 | ₹26.19 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD